205 related articles for article (PubMed ID: 38500203)
21. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video).
Patil G; Dalal A; Maydeo A
Dig Endosc; 2020 Jul; 32(5):745-752. PubMed ID: 31834663
[TBL] [Abstract][Full Text] [Related]
22. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
[TBL] [Abstract][Full Text] [Related]
23. New Perspectives in Endoscopic Treatment of Gastroesophageal Reflux Disease.
Calabrese F; Poletti V; Auriemma F; Paduano D; Gentile C; Facciorusso A; Franchellucci G; De Marco A; Brandaleone L; Ofosu A; Samanta J; Ramai D; De Luca L; Al-Lehibi A; Zuliani W; Hassan C; Repici A; Mangiavillano B
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370952
[TBL] [Abstract][Full Text] [Related]
24. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
Yadlapati R; DeLay K
Med Clin North Am; 2019 Jan; 103(1):15-27. PubMed ID: 30466671
[TBL] [Abstract][Full Text] [Related]
25. Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.
Inoue H; Yamamoto K; Shimamura Y; Azuma D; Ushikubo K; Okada H; Kimoto Y; Nishikawa Y; Tanaka I; Tanabe M; Onimaru M; Navarro MJ
Dig Endosc; 2024 Jun; 36(6):690-698. PubMed ID: 37899073
[TBL] [Abstract][Full Text] [Related]
26. Tailoring Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease.
Bakhos CT; Abbas AE; Petrov RV
Gastroenterol Clin North Am; 2020 Sep; 49(3):467-480. PubMed ID: 32718565
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic fundoplication for gastroesophageal reflux disease.
Frazzoni M; Piccoli M; Conigliaro R; Frazzoni L; Melotti G
World J Gastroenterol; 2014 Oct; 20(39):14272-9. PubMed ID: 25339814
[TBL] [Abstract][Full Text] [Related]
28. The status of endoscopic therapies for gastroesophageal reflux disease.
Kolb JM; Chang KJ
Curr Opin Gastroenterol; 2023 Jul; 39(4):326-332. PubMed ID: 37265186
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
McCarty TR; Itidiare M; Njei B; Rustagi T
Endoscopy; 2018 Jul; 50(7):708-725. PubMed ID: 29625507
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic and laparoscopic treatment of gastroesophageal reflux.
Watson DI; Immanuel A
Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):235-43. PubMed ID: 20350269
[TBL] [Abstract][Full Text] [Related]
31. Refractory Gastroesophageal Reflux Disease: A Management Update.
Rettura F; Bronzini F; Campigotto M; Lambiase C; Pancetti A; Berti G; Marchi S; de Bortoli N; Zerbib F; Savarino E; Bellini M
Front Med (Lausanne); 2021; 8():765061. PubMed ID: 34790683
[TBL] [Abstract][Full Text] [Related]
32. Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends.
Kasugai K; Ogasawara N
Intern Med; 2024 Jan; 63(1):1-10. PubMed ID: 36927966
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of endoscopic antireflux mucosectomy
Sui X; Gao X; Zhang L; Zhang B; Zhong C; Chen Y; Wang X; Li D; Wu W; Li L
Ann Transl Med; 2022 Jun; 10(12):660. PubMed ID: 35845516
[TBL] [Abstract][Full Text] [Related]
34. Antireflux mucosectomy for managing reflux symptoms in an obese patient post laparoscopic sleeve gastrectomy.
Patil G; Iyer A; Dalal A; Maydeo A
Scand J Gastroenterol; 2019 Dec; 54(12):1494-1497. PubMed ID: 31791169
[TBL] [Abstract][Full Text] [Related]
35. Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication.
Wong HJ; Su B; Attaar M; Kuchta K; Stearns S; Linn JG; Haggerty SP; Denham W; Ujiki MB
Surg Endosc; 2021 Dec; 35(12):7174-7182. PubMed ID: 33237465
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic techniques for treating gastroesophageal reflux.
Reyes Genere J; Wang KK
Curr Opin Gastroenterol; 2018 Sep; 34(5):288-294. PubMed ID: 30067561
[TBL] [Abstract][Full Text] [Related]
37. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
38. Clinical feasibility of a new antireflux ablation therapy on gastroesophageal reflux disease (with video).
Hernández Mondragón OV; Zamarripa Mottú RA; García Contreras LF; Gutiérrez Aguilar RA; Solórzano Pineda OM; Blanco Velasco G; Murcio Perez E
Gastrointest Endosc; 2020 Dec; 92(6):1190-1201. PubMed ID: 32343977
[TBL] [Abstract][Full Text] [Related]
39. Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?
Jain D; Singhal S
Clin Endosc; 2016 Mar; 49(2):147-56. PubMed ID: 26878326
[TBL] [Abstract][Full Text] [Related]
40. Does the presence of an esophageal motor disorder influence the response to anti-reflux mucosectomy (ARMS) for refractory GERD?
Onana Ndong P; Gonzalez JM; Beyrne A; Barthet M; Vitton V
Scand J Gastroenterol; 2024 Jun; 59(6):639-646. PubMed ID: 38497142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
